@article {2396, title = {Effective Dose of Cocoa as a Preemptive Analgesic and Anti- Inflammatory Agent Assessed through Pain Scale and Tumor Necrosis Factor Alpha (TNF-α) in an Acute Pain Animal Model}, journal = {Pharmacognosy Journal}, volume = {16}, year = {2024}, month = {October 2024}, pages = {1134-1137}, type = {Research Article}, chapter = {1134}, abstract = {

Background: Pain is a significant issue for 40-50\% of hospital patients, with 10-50\% of acute pain cases potentially progressing to chronic pain. Pain-associated inflammation often involves the release of mediators, including Tumor Necrosis Factor Alpha (TNF-α). Cocoa beans contain polyphenols, catechins, anthocyanidins, and proanthocyanidins, compounds believed to possess analgesic properties. This study aims to assess cocoa{\textquoteright}s potential as an oral preemptive analgesic agent in an acute pain mouse model, with an emphasis on its impact on inflammation through TNF-α levels. Methods: This true experimental study involved 24 male white mice split into four groups: a control group (K0) receiving a placebo, a treatment group receiving 15 mg/kg BW oral paracetamol (Kpct), a treatment group receiving 0.5 mg/g BW cocoa (K1), and a treatment group receiving 1 mg/g BW cocoa (K2). Pain response was measured using TNF-α levels and the von Frey test. The Kruskal-Wallis test and One-Way ANOVA were employed for statistical analysis. Results: Cocoa at doses of 0.5 mg/g BW and 1 mg/g BW substantially reduced TNF-α levels (75.82 {\textpm} 7.77 and 70.79 {\textpm} 11.50, respectively) compared to the control and paracetamol groups (98.22 {\textpm} 14.74 and 92.81 {\textpm} 2.64). On the first day, compared to the control group{\textquoteright}s 1.82 {\textpm} 0.78 von Frey values, the cocoa-treated groups{\textquoteright} values (6.20 {\textpm} 2.72 and 7.63 {\textpm} 4.11) were notably higher. There were no notable variations in von Frey values across the groups on the second day. However, a correlation was found between von Frey values on the first and second days. Conclusion: Cocoa can potentially serve as an effective preemptive analgesic agent, reducing pain and inflammation primarily by reducing TNF-α levels. These results provide validity to the use of cocoa as an alternative therapy in acute pain management.

}, keywords = {Cocoa, Pain, Pain Degree Analgesia, TNF-α}, doi = {10.5530/pj.2024.16.185}, author = {Herry Cahya Fathani and Herdiani Sulistyo Putri and Prananda Surya Airlangga and Christrijogo Sumartono Waloejo and Ira Sari Yudaniayanti and Pudji Lestari} }